Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.50 (8.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.25
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health amends agreement with partner Sacco

Wed, 11th Mar 2020 15:08

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary, ProBiotix Health, has signed a new global manufacturing and supply agreement with Sacco to modify and extend their existing relationship through to the end of 2023.
The AIM-traded firm said that under the terms of the agreement, Sacco would manufacture 'LPLDL' for ProBiotix under a global non-exclusive licence for the dietary supplement and food and dairy markets, as well as an exclusive licence for the drug and biotherapeutic market.

It said the agreement changed the original profit-sharing agreement of August 2017 to a manufacture-and-supply agreement, with pricing discounts for increasing sales volumes.

OptiBiotix said that would allow it to benefit from a reduced price of goods as sales volumes grow, and provide more evenly distributed income throughout the year.

The agreement also included commission payments from Sacco, for LPLDL sold to dairy customers.

"We are pleased to announce this agreement with Sacco, which extends our relationship with them for the next four years," said ProBiotix chief executive officer Steve Prescott.

"Sacco's commitment to manufacturing excellence, including the recently announced pharma cGMP validation of LPLDL, and their ability to manufacture of LPLDL in multiple facilities gives us confidence of a quality product and uninterrupted supply.

"The changes to this agreement reflect the focus on building a profitable business as we renegotiate supply agreements with partners as sales volumes grow to increase margins."

At 1456 GMT, shares in OptiBiotix Health were down 4.47% at 40.6p.
More News
22 Sep 2020 10:05

OptiBiotix enters new licensing deal with HiLife Vitamins

(Sharecast News) - Life sciences company OptiBiotix Health has entered into a non-exclusive license agreement for 'SlimBiome Medical' with HiLife Vitamins & Herbs, it announced on Tuesday.

Read more
17 Sep 2020 17:05

IN BRIEF: OptiBiotix Signs Distribution Deal For LPLDL In Brazil

IN BRIEF: OptiBiotix Signs Distribution Deal For LPLDL In Brazil

Read more
17 Sep 2020 08:57

OptiBiotix Health strikes deal with Ayalla in Brazil

(Sharecast News) - Life sciences company OptiBiotix Health announced on Thursday that its wholly-owned subsidiary ProBiotix Health has entered into an exclusive distribution agreement with Ayalla Marketing, for the distribution of its cholesterol reducing probiotic 'LPLDL' as an ingredient and as four finished products within the 'CholBiome' portfolio, for Brazil.

Read more
15 Sep 2020 22:08

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

Read more
15 Sep 2020 08:49

OptiBiotix signs manufacturing deal with unnamed US firm

(Sharecast News) - Life sciences company OptiBiotix Health has entered into an agreement with an unnamed US company, it announced on Tuesday, for the large-scale manufacture and commercialisation of a number of 'SweetBiotix' products.

Read more
11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Read more
5 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

Read more
5 Aug 2020 15:42

OptiBiotix Health extends terms of licence agreement with OptiPharm

(Sharecast News) - Life sciences company OptiBiotix Health has extended the terms of its original exclusive licence agreement for 'OptiBiome' with OptiPharm, it said on Wednesday, which was initially announced on 31 March.

Read more
23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

Read more
20 Jul 2020 15:30

IN BRIEF: OptiBiotix Reports Sales Surge From Weight Loss Products

IN BRIEF: OptiBiotix Reports Sales Surge From Weight Loss Products

Read more
20 Jul 2020 09:25

OptiBiotix sees serious surge in sales in first half

(Sharecast News) - OptiBiotix Health said on Monday that invoiced sales of its 'LPLDL' and 'SlimBiome' products as ingredients or final products totalled £0.74m in the first half of its financial year, representing a 398% year-on-year increase.

Read more
16 Jul 2020 13:57

UK TRADING UPDATE SUMMARY: LoopUp Set To Beat Expectations For 2020

UK TRADING UPDATE SUMMARY: LoopUp Set To Beat Expectations For 2020

Read more
14 Jul 2020 20:12

IN BRIEF: OptiBiotix Extends Terms To Include WellBiome In Germany

IN BRIEF: OptiBiotix Extends Terms To Include WellBiome In Germany

Read more
6 Jul 2020 16:56

IN BRIEF: OptiBiotix Expands WellBiome Distribution Pact

IN BRIEF: OptiBiotix Expands WellBiome Distribution Pact

Read more
2 Jul 2020 16:15

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.